The interaction of the drug compstatin with two ancient, co-evolved human systems points to new ways for reducing clotting during dialysis for end-stage kidney disease and multiple organ failure due ...

Compstatin works by blocking human complement, the immune system's passive alarm network that detects pathogens in the blood. Unfortunately, complement can also attack healthy tissue, and a variety of ...

Genetically engineered tumor-selective vaccinia virus (VV) has been demonstrated to be a highly effective oncolytic agent, but immune clearance may limit its therapeutic potential. As previously ...

Four years after being spun out of Potentia Pharmaceuticals, Apellis Pharmaceuticals said today it will acquire Potentia and intellectual property rights to its APL-2. The complement inhibitor ...

PHILADELPHIA – The interaction of the drug compstatin with two ancient, co-evolved human systems points to new ways for reducing clotting during dialysis for end-stage kidney disease and multiple ...

(Philadelphia, PA/Princeton, NJ) – The tedious laboratory trial-and-error method for refining protein/peptide-based medicines could be accelerated and complemented ...